Householder Group Estate & Retirement Specialist’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$12K Sell
128
-353
-73% -$37.6K 0.01% 351
2024
Q3
$55K Sell
481
-110
-19% -$12.5K 0.02% 467
2024
Q2
$62K Buy
591
+101
+21% +$10.1K 0.02% 443
2024
Q1
$47.4K Buy
490
+292
+147% +$29.9K 0.01% 482
2023
Q4
$19K Buy
198
+45
+29% +$4.34K 0.01% 655
2023
Q3
$15.6K Buy
+153
New +$15.5K 0.01% 691
2023
Q1
$14K Sell
153
-20
-12% -$1.75K 0.01% 718
2022
Q4
$15K Hold
173
0.02% 193
2022
Q3
$13K Buy
+173
New +$14.3K 0.01% 673

Other funds holding NVS

Householder Group Estate & Retirement Specialist's NVS Position: Q4 2024 in Review

Householder Group Estate & Retirement Specialist reduced its Novartis (NVS) stake by 73% in Q4 2024, selling an estimated $37.6K and leaving 128 shares worth $12K. The position accounts for 0.01% of the portfolio, ranked #351.

Householder Group Estate & Retirement Specialist first reported a position in NVS in Q3 2022 and has held it in 9 quarters since. The position peaked at $62K in Q2 2024. 1,341 funds tracked by Wall St. Rank hold NVS as of Q4 2024.

  • Householder Group Estate & Retirement Specialist held 128 shares of Novartis worth $12K as of Q4 2024.
  • Householder Group Estate & Retirement Specialist sold 353 Novartis shares in Q4 2024, an estimated $37.6K.
  • Novartis made up 0.01% of Householder Group Estate & Retirement Specialist's portfolio in Q4 2024, its #351 holding.
  • Householder Group Estate & Retirement Specialist first reported a position in Novartis in Q3 2022 and has held it in 9 quarters since.
  • Householder Group Estate & Retirement Specialist's Novartis position peaked at $62K in Q2 2024.
  • 1,341 funds tracked by Wall St. Rank held Novartis as of Q4 2024.

Based on Householder Group Estate & Retirement Specialist's 13F filing for Q4 2024, filed 15 Jan 2025.